Senti Biosciences Holdings, Inc. (SNTI)
Last updated: 2026-10-21 13:37:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Senti Biosciences Holdings, Inc. (SNTI) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.22, with a market capitalization of $7.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.21 to $2.88. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.06M | |
$0.22 | |
$87.70 | |
$0.21 | |
$0.23 | |
10.46K | |
871.40K | |
-- | |
$2.88 | |
$0.21 | |
-- | |
-- |
Senti Biosciences Holdings, Inc. (SNTI) Stock Price Today
Senti Biosciences Holdings, Inc. (SNTI) is currently trading at $0.22 as of 2026-10-21 13:32:00, down 2.94% ($0.01) from the previous close of $0.23
During today's regular trading session, SNTI has traded between $0.21 and $87.70, with a trading volume of 10.46K shares. The current price is near the lower end of today's range.
Senti Biosciences Holdings, Inc. (SNTI) 7-Day Stock Price Change
Over the past seven days, Senti Biosciences Holdings, Inc. (SNTI) moved from $0.32 to $0.22, representing a decline of 30.63% ($0.10).
The stock traded between $0.21 and $0.32 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.39 million shares, up versus the previous seven-day period, indicating higher trading activity.
SNTI 52-Week Price Position
Position in Range: 0.4%
SNTI is currently trading at $0.22, placing it 0.4% of the way from its 52-week low of $0.21 to its 52-week high of $2.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Senti Biosciences Holdings, Inc. (SNTI)?
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
Senti Biosciences Holdings, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 39 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Senti Biosciences Holdings, Inc. (SNTI) Stock on MEXC
Eligible investors can buy real shares of Senti Biosciences Holdings, Inc. (SNTI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Senti Biosciences Holdings, Inc. (SNTI) stock price today?
2.Is SNTI stock going up or down today?
3.What is SNTI pre-market price?
4.What is SNTI after-hours price?
5.Is SNTI stock trading now?
6.Where does SNTI sit relative to its 52-week high and low?
7.What sector is Senti Biosciences Holdings, Inc. in?
8.What is Senti Biosciences Holdings, Inc.'s market capitalization and where is it listed?
9.How is SNTI valued in terms of P/E ratio and EPS?
10.Does Senti Biosciences Holdings, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SNTI Stock Calculator
Estimate the value between SNTI shares and USD.
SNTI Shares to USD
1.00 SNTI shares = 0.221 USD
Calculations are estimates based on the latest available price and are for reference only.



